These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
189 related articles for article (PubMed ID: 18269681)
1. High omalizumab dose controls recurrent reactions to venom immunotherapy in indolent systemic mastocytosis. Kontou-Fili K Allergy; 2008 Mar; 63(3):376-8. PubMed ID: 18269681 [No Abstract] [Full Text] [Related]
2. Safety and effectiveness of immunotherapy in patients with indolent systemic mastocytosis presenting with Hymenoptera venom anaphylaxis. González de Olano D; Alvarez-Twose I; Esteban-López MI; Sánchez-Muñoz L; de Durana MD; Vega A; García-Montero A; González-Mancebo E; Belver T; Herrero-Gil MD; Fernández-Rivas M; Orfao A; de la Hoz B; Castells MC; Escribano L J Allergy Clin Immunol; 2008 Feb; 121(2):519-26. PubMed ID: 18177694 [TBL] [Abstract][Full Text] [Related]
3. Issues in stinging insect allergy immunotherapy: a review. Finegold I Curr Opin Allergy Clin Immunol; 2008 Aug; 8(4):343-7. PubMed ID: 18596592 [TBL] [Abstract][Full Text] [Related]
4. Mastocytosis and insect venom allergy: diagnosis, safety and efficacy of venom immunotherapy. Niedoszytko M; de Monchy J; van Doormaal JJ; Jassem E; Oude Elberink JN Allergy; 2009 Sep; 64(9):1237-45. PubMed ID: 19627278 [TBL] [Abstract][Full Text] [Related]
5. Usefulness of Omalizumab and Sting Challenge Test in Hymenoptera Venom Allergy and Mastocytosis. González-de-Olano D; Padial-Vilchez MA; Núñez-Acevedo B; de-Calzada-Bustingorri MP; de-Andrés-Martín A; Caldas C; Piris-Villaespesa M; de-la-Hoz-Caballer B J Investig Allergol Clin Immunol; 2019; 29(4):318-320. PubMed ID: 30957757 [No Abstract] [Full Text] [Related]
6. When yellow jackets attack: recurrent and severe anaphylactic reactions to insect bites and stings. Pollyea DA; George TI; Corless C; Gotlib J Am J Hematol; 2009 Dec; 84(12):843-6. PubMed ID: 19862831 [No Abstract] [Full Text] [Related]
7. Fatal anaphylactic sting reaction in a patient with mastocytosis. Wagner N; Fritze D; Przybilla B; Hagedorn M; Ruëff F Int Arch Allergy Immunol; 2008; 146(2):162-3. PubMed ID: 18204283 [TBL] [Abstract][Full Text] [Related]
8. Prolonged high-dose omalizumab is required to control reactions to venom immunotherapy in mastocytosis. Kontou-Fili K; Filis CI Allergy; 2009 Sep; 64(9):1384-5. PubMed ID: 19432937 [No Abstract] [Full Text] [Related]
9. Allergen specific immunotherapy is safe and effective in patients with systemic mastocytosis and Hymenoptera allergy. Bonadonna P; Zanotti R; Caruso B; Castellani L; Perbellini O; Colarossi S; Chilosi M; Dama A; Schiappoli M; Pizzolo G; Senna G; Passalacqua G J Allergy Clin Immunol; 2008 Jan; 121(1):256-7. PubMed ID: 18206512 [No Abstract] [Full Text] [Related]
10. Venom immunotherapy reduces large local reactions to insect stings. Golden DB; Kelly D; Hamilton RG; Craig TJ J Allergy Clin Immunol; 2009 Jun; 123(6):1371-5. PubMed ID: 19443022 [TBL] [Abstract][Full Text] [Related]
11. Clonal mast cell disorders in patients with systemic reactions to Hymenoptera stings and increased serum tryptase levels. Bonadonna P; Perbellini O; Passalacqua G; Caruso B; Colarossi S; Dal Fior D; Castellani L; Bonetto C; Frattini F; Dama A; Martinelli G; Chilosi M; Senna G; Pizzolo G; Zanotti R J Allergy Clin Immunol; 2009 Mar; 123(3):680-6. PubMed ID: 19135713 [TBL] [Abstract][Full Text] [Related]
12. Negative venom skin test results and mastocytosis. Kränke B; Sturm G; Aberer W J Allergy Clin Immunol; 2004 Jan; 113(1):180-1. PubMed ID: 14713932 [No Abstract] [Full Text] [Related]
13. Omalizumab as a desensitizing agent and treatment in mastocytosis: a review of the literature and case report. Sokol KC; Ghazi A; Kelly BC; Grant JA J Allergy Clin Immunol Pract; 2014; 2(3):266-70. PubMed ID: 24811015 [TBL] [Abstract][Full Text] [Related]
14. Anaphylaxis to insect sting associated with urticaria pigmentosa. Kim DC; Horan R Allergy Asthma Proc; 2003; 24(3):175-8. PubMed ID: 12866320 [TBL] [Abstract][Full Text] [Related]
15. Imported fire ant hypersensitivity and mastocytosis: A case series of successful venom immunotherapy. Nath P; Adams K; Schapira R; Edwards K Ann Allergy Asthma Immunol; 2019 May; 122(5):541-542. PubMed ID: 30831255 [No Abstract] [Full Text] [Related]
16. Cutaneous manifestations in Hymenoptera and Diptera anaphylaxis: relationship with basal serum tryptase. Potier A; Lavigne C; Chappard D; Verret JL; Chevailler A; Nicolie B; Drouet M Clin Exp Allergy; 2009 May; 39(5):717-25. PubMed ID: 19302252 [TBL] [Abstract][Full Text] [Related]
17. [Mastocytosis: an important differential diagnosis in anaphylactoid reaction to Hymenoptera sting. A case report and overview of clinical aspects, diagnosis and current therapy of mastocytosis]. Bucher C; Simic P; Furrer J; Wüthrich B Praxis (Bern 1994); 2000 Mar; 89(10):411-8. PubMed ID: 10731856 [TBL] [Abstract][Full Text] [Related]
18. Beekeepers anaphylaxis: successful immunotherapy covered by omalizumab. Schulze J; Rose M; Zielen S Allergy; 2007 Aug; 62(8):963-4. PubMed ID: 17484729 [No Abstract] [Full Text] [Related]